Gainers
- Neoleukin Therapeutics NLTX stock moved upwards by 33.3% to $0.71 during Thursday's regular session. Neoleukin Therapeutics's stock is trading at a volume of 9.5 million shares as of 12:30 EST. This is 3821.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.1 million.
- Biophytis BPTS shares increased by 32.0% to $0.66. As of 12:30 EST, Biophytis's stock is trading at a volume of 2.3 million, which is 304.8% of its average full-day volume over the last 100 days. The company's market cap stands at $13.4 million.
- Avenue Therapeutics ATXI stock increased by 24.02% to $1.29. Avenue Therapeutics's stock is trading at a volume of 5.6 million shares as of 12:30 EST. This is 626.8% of its average full-day volume over the last 100 days. The company's market cap stands at $7.1 million.
- Assertio Holdings ASRT shares increased by 17.28% to $6.99. Assertio Holdings's stock is trading at a volume of 3.7 million shares as of 12:30 EST. This is 229.4% of its average full-day volume over the last 100 days. The company's market cap stands at $337.5 million. As per the news, the Q4 earnings report came out yesterday.
- OpGen OPGN stock moved upwards by 17.24% to $1.16. Trading volume for OpGen's stock is 1.2 million as of 12:30 EST. This is 242.8% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 million.
- Macrogenics MGNX stock increased by 15.63% to $6.36. Trading volume for Macrogenics's stock is 599.3K as of 12:30 EST. This is 96.0% of its average full-day volume over the last 100 days. The company's market cap stands at $390.9 million.
Losers
- InVivo Therapeutics Hldg NVIV stock declined by 46.0% to $1.15 during Thursday's regular session. The current volume of 1.4 million shares is 2167.7% of InVivo Therapeutics Hldg's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $3.2 million.
- Akebia Therapeutics AKBA stock fell 22.82% to $0.8. As of 12:30 EST, this security is trading at a volume of 5.4 million shares, making up 226.4% of its average full-day volume over the last 100 days. The company's market cap stands at $146.4 million. The company's, Q4 earnings came out today.
- Fulcrum Therapeutics FULC stock declined by 19.65% to $5.03. As of 12:30 EST, this security is trading at a volume of 1.9 million shares, making up 173.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $310.1 million. The company's, Q4 earnings came out today.
- iBio IBIO shares decreased by 16.37% to $1.64. Trading volume for this security as of 12:30 EST is 943.6K, which is 28.0% of its average full-day volume over the last 100 days. The company's market cap stands at $20.2 million.
- Predictive Oncology POAI stock declined by 15.79% to $0.35. Trading volume for Predictive Oncology's stock is 1.1 million as of 12:30 EST. This is 295.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.1 million.
- OptimizeRx OPRX shares decreased by 14.97% to $13.81. As of 12:30 EST, OptimizeRx's stock is trading at a volume of 558.1K, which is 336.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $236.8 million. As per the news, the Q4 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in